medigraphic.com
A partir del año 2010, la Revista Oficial del INER cambió a NCT (Neumología y Cirugía de Tórax)

 Ver actualización

2008, Number 3

<< Back Next >>

Rev Inst Nal Enf Resp Mex 2008; 21 (3)

Nutritional management of bronchopulmonary dysplasia

Corpus ECR, Pérez-Guzmán C, García PSR, Gutiérrez-Mendoza I, Serna-Vela FJ, Góngora-Ortega J

Language: Spanish
References: 47
Page: 235-240
PDF size: 79.22 Kb.


ABSTRACT

Bronchopulmonary dysplasia (BPD) is the lung damage produced by mechanical ventilatory assistance in premature newborns and favored by respiratory infections. It is the first cause of respiratory morbidity in premature children that survive more than 28 days postnatally. In children with BPD, growth is slow and is one of the most important indicators of their health status. Energetic needs vary during the evolution of the disease and in relation to its severity, increasing from 25 to 50% in comparison with healthy infants. Caloric needs in children with BPD can reach up to 160-180 kcal/kg/day. Nutritional management of BPD children is based in limiting carbohydrates and increasing proteins up to 4 g/kg/day. Supplements of vitamins A, C and E, and even inositol, are recommended; administration of copper, zinc, selenium and manganese are useful for growth.


REFERENCES

  1. Citado por: Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163:1723-1729.

  2. Bhandari A, Bhandari V. Bronchopulmonary dysplasia: an update. Symposium: Neonatology II: Evidence and experience in neonatal medicine. Indian J Pediatr 2007;74:73-77.

  3. Ministerio de Salud. Guía Clínica. Displasia broncopulmonar del prematuro. Santiago: Minsal;2005.

  4. Bancalari E, González A. Clinical course and lung function abnormalities during development of neonatal chronic lung disease. In: Bland RD, Coalson JJ, editors. Chronic lung disease in early infancy. New York: Marcel Dekker; 2000.p.41-64.

  5. Pérez G, Barrio Gómez de Argüero MI, Luna C, et ál. Displasia broncopulmonar. Enfermedad pulmonar crónica. Protocolos diagnósticos y terapéuticos en pediatría. AEPED 2003;3:235-244.

  6. Stevenson DK, Wright LL, Lemons JA, et ál. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1993 through December 1994. Am J Obstet Gynecol 1998;179(6 Pt 1):1632-1639.

  7. Awasthi S, Coalson JJ, Crouch E, Yang F, King RJ. Surfactant proteins A and D in premature baboons with chronic lung injury (Bronchopulmonary dysplasia). Evidence for an inhibition of secretion. Am J Respir Crit Care Med 1999;160:942-949.

  8. Awasthi S, Coalson JJ, Yoder BA, Crouch E, King RJ. Deficiencies in lung surfactant proteins A and D are associated with lung infection in very premature neonatal baboons. Am J Respir Crit Care Med 2001;163: 389-397.

  9. Coalson JJ, Winter VT, Siler-Khodr T, Yoder BA. Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med 1999;160:1333-1346.

  10. Albertine KH, Jones GP, Starcher BC, et ál. Chronic lung injury in preterm lambs. Disordered respiratory tract development. Am J Respir Crit Care Med 1999;159:945-958.

  11. Coalson JJ. Pathology of new bronchopulmonary dysplasia. Semin Neonatol 2003;8:73-81.

  12. Thomson MA, Yoder BA, Winter VT, et ál. Treatment of immature baboons for 28 days with early nasal continuous positive airway pressure. Am J Respir Crit Care Med 2004;169:1054-1062.

  13. Coalson JJ, Winter V, deLemos RA. Decreased alveolarization in baboon survivors with bronchopulmonary dysplasia. Am J Respir Crit Care Med 1995;152:640-646.

  14. De los Santos R, Seidenfeld JJ, Anzueto A, et ál. One hundred percent oxygen lung injury in adult baboons. Am Rev Respir Dis 1987;136:657-661.

  15. Coalson JJ, Kuehl TJ, Prihoda TJ, deLemos. Diffuse alveolar damage in the evolution of bronchopulmonary dysplasia in the baboon. Pediatr Res 1988;24:357-366.

  16. Frid MG, Aldashev AA, Nemenoff RA, Higashito R, Westcott JY, Stenmark KR. Subendothelial cells from normal bovine arteries exhibit autonomous growth and constitutively activated intracellular signaling. Arterioscler Thromb Vasc Biol 1999;19:2884-2893.17.

  17. Das M, Dempsey EC, Bouchey D, Reyland ME, Stenmark KR. Chronic hypoxia induces exaggerated growth responses in pulmonary artery adventitial fibroblasts: potential contribution of specific protein kinase c isozymes. Am J Respir Cell Mol Biol 2000;22:15-25.

  18. Warner BB, Stuart LA, Papes RA, Wispé JR. Functional and pathological effects of prolonged hyperoxia in neonatal mice. Am J Physiol 1998;275(1 Pt 1):L110-L117.

  19. Hjalmarson O, Sandberg KL. Lung function at term reflects severity of bronchopulmonary dysplasia. J Pediatr 2005;146:86-90.

  20. Van Marter LJ, Allred EN, Pagano M, et ál. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? Pediatrics 2000;105:1194-1201.

  21. Carlton DP, Albertine KH, Cho SC, Lont M, Bland RD. Role of neutrophils in lung vascular injury and edema after premature birth in lambs. J Appl Physiol 1997; 83:1307-1317.

  22. Naik AS, Kallapur SG, Bachurski CJ, et ál. Effects of ventilation with different positive end-expiratory pressures on cytokine expression in the preterm lamb lung. Am J Respir Crit Care Med 2001;164:494-498.

  23. Carlton DP, Albertine KH, Cho SC, Lont M, Bland RD. Role of neutrophils in lung vascular injury and edema after premature birth in lambs. J Appl Physiol 1997; 83:1307-1317.

  24. Rämet M, Haataja R, Marttila R, Floros J, Hallman M. Association between the surfactant protein A (SP-A) gene locus and respiratory-distress syndrome in the Finnish population. Am J Hum Genet 2000;66:1569-1579.

  25. Mitchell SH, Teague WG. Reduced gas transfer at rest and during exercise in school-age survivors of bronchopulmonary dysplasia. Am J Respir Crit Care Med 1998;157(5 Pt 1):1406-1412.

  26. Mourani PM, Sontag MK, Younoszai A, Ivy DD, Abman SH. Clinical utility of echocardiography for the diagnosis and management of pulmonary vascular disease in young children with chronic lung disease. Pediatrics 2008;121:317-325.

  27. Khemani E, McElhinney DB, Rhein L, et ál. Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era. Pediatrics 2007;120: 1260-1269.

  28. Mueller DH. Nutrioterapia médica en enfermedades pulmonares. En: Mahan LK, Escott-Stump S, editores. Nutrición y dietoterapia de Krause. 10ª ed. México: McGraw-Hill, Interamericana;2001. p.883-901.

  29. De Meer K, Westerterp KR, Houwen RH, Brouwers HA, Berger R, Okken A. Total energy expenditure in infants with bronchopulmonary dysplasia is associated with respiratory status. Eur J Pediatr 1997;156:299-304.

  30. Biniwale MA, Ehrenkranz RA. The role of nutrition in the prevention and management of bronchopulmonary dysplasia. Semin Perinatol 2006;30: 200-208.

  31. Kurzner SI, Garg M, Bautista DB, et ál. Growth failure in infants with bronchopulmonary dysplasia: nutrition and elevated resting metabolic expenditure. Pediatrics 1988;81:379-384.

  32. Johnson DB, Cheney C, Monsen ER. Nutrition and feeding in infants with bronchopulmonary dysplasia after initial hospital discharge: risk factors for growth failure. J Am Diet Assoc 1998;98:649-656.

  33. Bott L, Béghin L, Pierrat V, Thumerelle C, Gottrand F. Nutrition and bronchopulmonary dysplasia. Arch Pediatr 2004;11:234-239.

  34. Oh W. Nutritional management of infants with bronchopulmonary dysplasia. In: Farrell PM, Taussig LM, editors. Bronchopulmonary dysplasia and related chronic respiratory disorders. Ross Laboratories, Columbus, OH, 1986;96-104.

  35. Cueva JC. Alimentación en el primer año de vida postnatal. En: Asociación Mexicana de Pediatría, editores. Nutrición. Temas de pediatría. México: McGraw-Hill, Interamericana;1996.p.1-22.

  36. Ganzoni A, Heilig P, Schönenberger K, Hügli O, Fitting JW, Brändli O. High-caloric nutrition in chronic obstructive lung disease. Schweiz Rundsch Med Prax 1994;83:13-16.

  37. Wooldridge N. Pulmonary diseases. In: Queen P, Lang C, editors. Handbook of pediatric nutrition. Gaithersburg, MD: Aspen Publishers;1993. p. 442-446.

  38. American Thoracic Society Documents. Statement on the care of the child with chronic lung disease of infancy and childhood. Am J Respir Crit Care Med 2003; 168:356-396.

  39. Atkinson SA. Special nutritional needs of infants for prevention of and recovery from bronchopulmonary dysplasia. J Nutr 2001;131:942S-946S.

  40. Bancalari E, Wilson-Costello D, Iben SC. Management of infants with bronchopulmonary dysplasia in North America. Early Hum Dev 2005;81:171-179.

  41. Verma RP, McCulloch KM, Worrell L, Vidyasagar D. Vitamin A deficiency and severe bronchopulmonary dysplasia in very low birth-weight infants. Am J Perinatol 1996;13:389-393.

  42. Robbins ST, Fletcher AB. Early vs. delayed vitamin A supplementation in very-low-birth-weight infants. JPEN J Parenter Enteral Nutr 1993;17:220-225.

  43. Darlow BA, Graham PJ. Vitamin A supplementation to prevent mortality and short and long-term morbidity in very low birthweight infants. Cochrane Database Syst Rev 2007;(4):CD000501.

  44. Berger TM, Frei B, Rifai N, et ál. Early high dose antioxidant vitamins do not prevent bronchopulmonary dysplasia in premature baboons exposed to prolonged hyperoxia: a pilot study. Pediatr Res 1998;43:719-726.

  45. Hallman M, Bry K, Hoppu K, Lappi M, Pohjavuori M. Inositol supplementation in premature infants with respiratory distress syndrome. N Engl J Med 1992; 326:1233-1239.

  46. Bott L, Béghin L, Pierrat V, Thumerelle C, Gottrand F. Nutrition and bronchopulmonary dysplasia. Arch Pediatr 2004;11:234-239.

  47. Merz U, Peschgens T, Dott W, Hörnchen H. Selenium status and bronchopulmonary dysplasia in premature infants < 1,500 g. Z Geburtshilfe Neonatol 1998;202:203-206.




2020     |     www.medigraphic.com